<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01782079</url>
  </required_header>
  <id_info>
    <org_study_id>LB - 001</org_study_id>
    <nct_id>NCT01782079</nct_id>
  </id_info>
  <brief_title>L. Brevis CD2 Strain Persistence in Oral Cavity</brief_title>
  <official_title>Assessment of Probiotic Lactobacillus Brevis CD2 Strain Persistence in Oral Cavity. A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to select the optimal conditions for quantification in the oral&#xD;
      cavity of Lactobacillus brevis CD2, a probiotic strain contained in a commercially available&#xD;
      dietary supplement and to assess its persistency after oral administration. Different sets of&#xD;
      primers for L. brevis detection will be tested in real-time PCR reactions to find optimal&#xD;
      amplification efficiency and target specificity. Primers ability in the identification of L.&#xD;
      brevis DNA will be assessed in a pilot study conducted on 12 healthy volunteers clinically&#xD;
      free of oral pathologies. The subjects will take 3 tablets/day for 3 days and one tablet on&#xD;
      the 4th day. Clinical samples (dorsal surface of tongue, first molar, vestibular fornix and&#xD;
      saliva) will be collected at baseline (before beginning the trial), at T0 (in the morning&#xD;
      before the assumption of the last tablet) and 3, 6, and 9 hours after taking the last tablet.&#xD;
      The quantities of L. brevis DNA will be compared to the total number of bacteria present in&#xD;
      the samples. The activity of the enzyme arginine deiminase, responsible for oral pH&#xD;
      homeostasis (particularly abundant in the CD2 strain) will be also assessed in the saliva&#xD;
      samples before and after treatment, by HPLC measurements.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantification and persistency of Lactobacillus brevis CD2 after oral administration</measure>
    <time_frame>4 days</time_frame>
    <description>Mucosal surface colonization in various mouth sites will be assessed by measuring the number of bacteria by Real Time PCR. Quantities of L. brevis DNA will be compared to the total number of bacteria present in the samples.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arginine deiminase activity</measure>
    <time_frame>4 days</time_frame>
    <description>Enzyme activity, measured as the amount of citrulline formed per minute in the assay conditions, will be determined in saliva samples by HPLC measurements.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Oral Health</condition>
  <arm_group>
    <arm_group_label>L. brevis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>L. brevis</intervention_name>
    <arm_group_label>L. brevis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Healthy subjects with no oral cavity pathologies&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with oral diseases&#xD;
&#xD;
          -  Patients with systemic diseases&#xD;
&#xD;
          -  Celiac patients or subjects affected by allergic reactions to soy proteins&#xD;
&#xD;
          -  Use of antibiotics or other probiotics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universit√† La Sapienza</name>
      <address>
        <city>Roma</city>
        <zip>00185</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <study_first_submitted>January 18, 2013</study_first_submitted>
  <study_first_submitted_qc>January 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2013</study_first_posted>
  <last_update_submitted>March 22, 2013</last_update_submitted>
  <last_update_submitted_qc>March 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Luciana Mosca, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Lactobacillus brevis</keyword>
  <keyword>Oral health</keyword>
  <keyword>Bacterial adhesion</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

